Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke ...Middle East

EDEN PRAIRIE, Minn., May 3, 2023 /PRNewswire/ -- MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company's clinical trial to assess the safety and effectiveness of the Q™ Revascularization...

Hence then, the article about clinical trial enrollment complete for study of mivi q revascularization system that treats acute ischemic stroke was published today ( Wednesday 03/05/2023 - 10:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke )

Also on site :

• Macy’s Valley Fair shoppers thwart Rolex watch thieves
• RCB-W vs UPW-W Dream11 Prediction, Dream11 Playing XI, Today Match 5, WPL 2026
• Motional puts AI at center of robotaxi reboot as it targets 2026 for driverless service